GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 802 filers reported holding GLAXOSMITHKLINE PLC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $97,070,000 | +4593.9% | 2,228,500 | +3865.9% | 0.18% | +1572.7% |
| Q4 2020 | $2,068,000 | -87.7% | 56,192 | -87.4% | 0.01% | -89.7% |
| Q3 2020 | $16,789,000 | +729.1% | 446,052 | +798.5% | 0.11% | +664.3% |
| Q2 2020 | $2,025,000 | -46.5% | 49,646 | -44.0% | 0.01% | -53.3% |
| Q3 2019 | $3,782,000 | +3923.4% | 88,610 | +3841.7% | 0.03% | – |
| Q1 2019 | $94,000 | +118.6% | 2,248 | +100.0% | 0.00% | – |
| Q4 2018 | $43,000 | -81.0% | 1,124 | -82.4% | 0.00% | -100.0% |
| Q4 2017 | $226,000 | -87.2% | 6,374 | -85.1% | 0.01% | -89.0% |
| Q3 2017 | $1,760,000 | +124.2% | 42,922 | +135.1% | 0.08% | +134.3% |
| Q2 2017 | $785,000 | -98.1% | 18,259 | -98.3% | 0.04% | -86.8% |
| Q4 2016 | $40,493,000 | +19.7% | 1,051,489 | +34.1% | 0.27% | +10.4% |
| Q3 2016 | $33,829,000 | +1137.8% | 784,359 | +1003.4% | 0.24% | +608.8% |
| Q3 2015 | $2,733,000 | – | 71,084 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |